Skip to main content
Erschienen in: Quality of Life Research 2/2012

01.03.2012

Rasch analysis in the development of a simplified version of the national eye institute visual-function questionnaire-25 for utility estimation

verfasst von: Jonathan W. Kowalski, Anne M. Rentz, John G. Walt, Andrew Lloyd, Jeff Lee, Tracey A. Young, Wen-Hung Chen, Neil M. Bressler, Paul Lee, John E. Brazier, Ron D. Hays, Dennis A. Revicki

Erschienen in: Quality of Life Research | Ausgabe 2/2012

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Preference-based health measures value how people feel about the desirability of a health state. Generic measures may not effectively capture the impact of vision loss from ocular diseases. Disease-targeted measures could address this limitation. This study developed a vision-targeted health state classification system based on the National Eye Institute Visual Function Questionnaire-25 (NEI VFQ-25).

Methods

Secondary analysis of NEI VFQ-25 data from studies of patients with central (n = 932)- and peripheral-vision loss (n = 2,451) were used to develop a health state classification system. Classical test theory and Rasch analyses were used to identify a smaller set of NEI VFQ-25 items suitable for the central- and peripheral-vision-loss groups.

Results

Rasch analysis of the NEI VFQ-25 items using the peripheral vision–loss data indicated that 11 items fit a unidimensional model, while 14 NEI VFQ-25 items fit using the central-vision-loss data. Combining peripheral-vision-loss data and central-vision-loss data resulted in 9 items fitting a unidimensional model. Six items covering near vision, distance vision, social vision, role difficulties, vision dependency, and vision-related mental health were selected for the health-state classification.

Conclusions

The derived health-state classification system covers relevant domains of vision-related functioning and well-being.
Literatur
1.
Zurück zum Zitat Gold, M. R., Siegel, J. E., Russell, L. B., & Weinstein, M. C. (Eds.). (1996). Cost-effectiveness in health and medicine. New York: Oxford University Press. Gold, M. R., Siegel, J. E., Russell, L. B., & Weinstein, M. C. (Eds.). (1996). Cost-effectiveness in health and medicine. New York: Oxford University Press.
2.
Zurück zum Zitat Fryback, D. G., Dunham, N. C., Palta, M., Hanmer, J., Buechner, J., Cherepanov, D., et al. (2007). US norms for six generic health-related quality-of-life indexes from the national health measurement study. Medical Care, 45(12), 1162–1170.PubMedCrossRef Fryback, D. G., Dunham, N. C., Palta, M., Hanmer, J., Buechner, J., Cherepanov, D., et al. (2007). US norms for six generic health-related quality-of-life indexes from the national health measurement study. Medical Care, 45(12), 1162–1170.PubMedCrossRef
3.
Zurück zum Zitat Gold, M. R., Stevenson, D., & Fryback, D. G. (2002). HALYS and QALYS and DALYS, Oh My: Similarities and differences in summary measures of population health. Annual Review of Public Health, 23, 115–134.PubMedCrossRef Gold, M. R., Stevenson, D., & Fryback, D. G. (2002). HALYS and QALYS and DALYS, Oh My: Similarities and differences in summary measures of population health. Annual Review of Public Health, 23, 115–134.PubMedCrossRef
4.
Zurück zum Zitat Kaplan, R. M. (2005). Measuring quality of life for policy analysis: Past, present and the future. In W. R. Lenderking & D. A. Revicki (Eds.), Advancing health outcomes research methods and clinical applications. McClean, VA: International Society for Quality of Life Research. Kaplan, R. M. (2005). Measuring quality of life for policy analysis: Past, present and the future. In W. R. Lenderking & D. A. Revicki (Eds.), Advancing health outcomes research methods and clinical applications. McClean, VA: International Society for Quality of Life Research.
5.
Zurück zum Zitat Lipscomb, J., Drummond, M., Fryback, D., Gold, M., & Revicki, D. (2009). Retaining, and enhancing, the QALY. Value Health, 12(Suppl 1), S18–S26.PubMedCrossRef Lipscomb, J., Drummond, M., Fryback, D., Gold, M., & Revicki, D. (2009). Retaining, and enhancing, the QALY. Value Health, 12(Suppl 1), S18–S26.PubMedCrossRef
6.
Zurück zum Zitat Weinstein, M. C., Torrance, G., & McGuire, A. (2009). QALYs: The basics. Value Health, 12(Suppl 1), S5–S9.PubMedCrossRef Weinstein, M. C., Torrance, G., & McGuire, A. (2009). QALYs: The basics. Value Health, 12(Suppl 1), S5–S9.PubMedCrossRef
7.
Zurück zum Zitat Brazier, J., Czoski-Murray, C., Roberts, J., Brown, M., Symonds, T., & Kelleher, C. (2008). Estimation of a preference-based index from a condition-specific measure: The King’s health questionnaire. Medical Decision Making, 28(1), 113–126.PubMedCrossRef Brazier, J., Czoski-Murray, C., Roberts, J., Brown, M., Symonds, T., & Kelleher, C. (2008). Estimation of a preference-based index from a condition-specific measure: The King’s health questionnaire. Medical Decision Making, 28(1), 113–126.PubMedCrossRef
8.
Zurück zum Zitat Torrance, G. W. (1986). Measurement of health state utilities for economic appraisal. Journal of Health Economics, 5(1), 1–30.PubMedCrossRef Torrance, G. W. (1986). Measurement of health state utilities for economic appraisal. Journal of Health Economics, 5(1), 1–30.PubMedCrossRef
9.
Zurück zum Zitat Feeny, D., Furlong, W., Torrance, G. W., Goldsmith, C. H., Zhu, Z., DePauw, S., et al. (2002). Multiattribute and single-attribute utility functions for the health utilities index mark 3 system. Medical Care, 40(2), 113–128.PubMedCrossRef Feeny, D., Furlong, W., Torrance, G. W., Goldsmith, C. H., Zhu, Z., DePauw, S., et al. (2002). Multiattribute and single-attribute utility functions for the health utilities index mark 3 system. Medical Care, 40(2), 113–128.PubMedCrossRef
10.
Zurück zum Zitat Feeny, D., Torrance, G. W., & Furlong, W. (1996). Health utilities index. In B. Spilker (Ed.), Quality of life and pharmacoeconomics in clinical trials. Philadelphia, PA: Lippincott-Raven Press. Feeny, D., Torrance, G. W., & Furlong, W. (1996). Health utilities index. In B. Spilker (Ed.), Quality of life and pharmacoeconomics in clinical trials. Philadelphia, PA: Lippincott-Raven Press.
11.
Zurück zum Zitat The EuroQol Group. (1990). EuroQol–a new facility for the measurement of health-related quality of life. Health Policy, 16(3), 199–208.CrossRef The EuroQol Group. (1990). EuroQol–a new facility for the measurement of health-related quality of life. Health Policy, 16(3), 199–208.CrossRef
12.
Zurück zum Zitat Brooks, R., Rabin, R., & de Charro, F. (2003). The measurement and valuation of health status using EQ-5D: A European perspective. Dordrecht, Netherlands: Kluwer Academic Publishers. Brooks, R., Rabin, R., & de Charro, F. (2003). The measurement and valuation of health status using EQ-5D: A European perspective. Dordrecht, Netherlands: Kluwer Academic Publishers.
13.
Zurück zum Zitat Andresen, E. M., Rothenberg, B. M., & Kaplan, R. M. (1998). Performance of a self-administered mailed version of the quality of well-being (QWB-SA) questionnaire among older adults. Medical Care, 36(9), 1349–1360.PubMedCrossRef Andresen, E. M., Rothenberg, B. M., & Kaplan, R. M. (1998). Performance of a self-administered mailed version of the quality of well-being (QWB-SA) questionnaire among older adults. Medical Care, 36(9), 1349–1360.PubMedCrossRef
14.
Zurück zum Zitat Brown, G. C., Brown, M. M., Sharma, S., Stein, J. D., Roth, Z., Campanella, J. & Beauchamp, G. R. (2005). The burden of age-related macular degeneration: A value-based medicine analysis. Transactions of the American Ophthalmological Society, 103, 173–184; discussion 184–176. Brown, G. C., Brown, M. M., Sharma, S., Stein, J. D., Roth, Z., Campanella, J. & Beauchamp, G. R. (2005). The burden of age-related macular degeneration: A value-based medicine analysis. Transactions of the American Ophthalmological Society, 103, 173–184; discussion 184–176.
15.
Zurück zum Zitat Brown, M. M., Brown, G. C., Stein, J. D., Roth, Z., Campanella, J., & Beauchamp, G. R. (2005). Age-related macular degeneration: Economic burden and value-based medicine analysis. Canadian Journal of Ophthalmology, 40(3), 277–287.PubMed Brown, M. M., Brown, G. C., Stein, J. D., Roth, Z., Campanella, J., & Beauchamp, G. R. (2005). Age-related macular degeneration: Economic burden and value-based medicine analysis. Canadian Journal of Ophthalmology, 40(3), 277–287.PubMed
16.
Zurück zum Zitat Espallargues, M., Czoski-Murray, C. J., Bansback, N. J., Carlton, J., Lewis, G. M., Hughes, L. A., et al. (2005). The impact of age-related macular degeneration on health status utility values. Investigative Ophthalmology and Visual Science, 46(11), 4016–4023.PubMedCrossRef Espallargues, M., Czoski-Murray, C. J., Bansback, N. J., Carlton, J., Lewis, G. M., Hughes, L. A., et al. (2005). The impact of age-related macular degeneration on health status utility values. Investigative Ophthalmology and Visual Science, 46(11), 4016–4023.PubMedCrossRef
17.
Zurück zum Zitat National Institute for Health and Clinical Excellence. (2008). Guide to the methods of technology appraisal. National Institute for Health and Clinical Excellence. (2008). Guide to the methods of technology appraisal.
18.
Zurück zum Zitat Kaplan, R. M., Tally, S., Hays, R. D., Feeny, D., Ganiats, T. G., Palta, M. & Fryback, D. (2011). Responsiveness of five preference-based indexes in cataract and heart failure patients. Journal of Clinical Epidemiology, 64, 497–506. Kaplan, R. M., Tally, S., Hays, R. D., Feeny, D., Ganiats, T. G., Palta, M. & Fryback, D. (2011). Responsiveness of five preference-based indexes in cataract and heart failure patients. Journal of Clinical Epidemiology, 64, 497–506.
19.
Zurück zum Zitat Clarke, P., Gray, A., Legood, R., Briggs, A., & Holman, R. (2003). The impact of diabetes-related complications on healthcare costs: results from the United Kingdom prospective diabetes study (UKPDS study no. 65). Diabetic Medicine, 20(6), 442–450.PubMedCrossRef Clarke, P., Gray, A., Legood, R., Briggs, A., & Holman, R. (2003). The impact of diabetes-related complications on healthcare costs: results from the United Kingdom prospective diabetes study (UKPDS study no. 65). Diabetic Medicine, 20(6), 442–450.PubMedCrossRef
20.
Zurück zum Zitat Brown, M. M., Brown, G. C., Sharma, S., & Shah, G. (1999). Utility values and diabetic retinopathy. American Journal of Ophthalmology, 128(3), 324–330.PubMedCrossRef Brown, M. M., Brown, G. C., Sharma, S., & Shah, G. (1999). Utility values and diabetic retinopathy. American Journal of Ophthalmology, 128(3), 324–330.PubMedCrossRef
21.
Zurück zum Zitat Brown, G. C., Sharma, S., Brown, M. M., & Kistler, J. (2000). Utility values and age-related macular degeneration. Archives of Ophthalmology, 118(1), 47–51.PubMed Brown, G. C., Sharma, S., Brown, M. M., & Kistler, J. (2000). Utility values and age-related macular degeneration. Archives of Ophthalmology, 118(1), 47–51.PubMed
22.
Zurück zum Zitat Brown, M. M., Brown, G. C., Sharma, S., Landy, J., & Bakal, J. (2002). Quality of life with visual acuity loss from diabetic retinopathy and age-related macular degeneration. Archives of Ophthalmology, 120(4), 481–484.PubMed Brown, M. M., Brown, G. C., Sharma, S., Landy, J., & Bakal, J. (2002). Quality of life with visual acuity loss from diabetic retinopathy and age-related macular degeneration. Archives of Ophthalmology, 120(4), 481–484.PubMed
23.
Zurück zum Zitat Brazier, J., Roberts, J., & Deverill, M. (2002). The estimation of a preference-based measure of health from the SF-36. Journal of Health Economics, 21(2), 271–292.PubMedCrossRef Brazier, J., Roberts, J., & Deverill, M. (2002). The estimation of a preference-based measure of health from the SF-36. Journal of Health Economics, 21(2), 271–292.PubMedCrossRef
24.
Zurück zum Zitat Revicki, D. A., Leidy, N. K., Brennan-Diemer, F., Sorensen, S., & Togias, A. (1998). Integrating patient preferences into health outcomes assessment: The multiattribute Asthma symptom utility index. Chest, 114(4), 998–1007.PubMedCrossRef Revicki, D. A., Leidy, N. K., Brennan-Diemer, F., Sorensen, S., & Togias, A. (1998). Integrating patient preferences into health outcomes assessment: The multiattribute Asthma symptom utility index. Chest, 114(4), 998–1007.PubMedCrossRef
25.
Zurück zum Zitat Revicki, D. A., Leidy, N. K., Brennan-Diemer, F., Thompson, C., & Togias, A. (1998). Development and preliminary validation of the multiattribute Rhinitis symptom utility index. Quality of Life Research, 7(8), 693–702.PubMedCrossRef Revicki, D. A., Leidy, N. K., Brennan-Diemer, F., Thompson, C., & Togias, A. (1998). Development and preliminary validation of the multiattribute Rhinitis symptom utility index. Quality of Life Research, 7(8), 693–702.PubMedCrossRef
26.
Zurück zum Zitat Young, T., Yang, Y., Brazier, J. E., Tsuchiya, A., & Coyne, K. (2009). The first stage of developing preference-based measures: constructing a health-state classification using Rasch analysis. Quality of Life Research, 18(2), 253–265.PubMedCrossRef Young, T., Yang, Y., Brazier, J. E., Tsuchiya, A., & Coyne, K. (2009). The first stage of developing preference-based measures: constructing a health-state classification using Rasch analysis. Quality of Life Research, 18(2), 253–265.PubMedCrossRef
27.
Zurück zum Zitat Lenert, L. A., Sherbourne, C. D., Sugar, C., & Wells, K. B. (2000). Estimation of utilities for the effects of depression from the SF-12. Medical Care, 38(7), 763–770.PubMedCrossRef Lenert, L. A., Sherbourne, C. D., Sugar, C., & Wells, K. B. (2000). Estimation of utilities for the effects of depression from the SF-12. Medical Care, 38(7), 763–770.PubMedCrossRef
28.
Zurück zum Zitat Lo, P. S., Tong, M. C., Revicki, D. A., Lee, C. C., Woo, J. K., Lam, H. C., et al. (2006). Rhinitis symptom utility index (RSUI) in Chinese subjects: a multiattribute patient-preference approach. Quality of Life Research, 15(5), 877–887.PubMedCrossRef Lo, P. S., Tong, M. C., Revicki, D. A., Lee, C. C., Woo, J. K., Lam, H. C., et al. (2006). Rhinitis symptom utility index (RSUI) in Chinese subjects: a multiattribute patient-preference approach. Quality of Life Research, 15(5), 877–887.PubMedCrossRef
29.
Zurück zum Zitat Mangione, C. M., Lee, P. P., Gutierrez, P. R., Spritzer, K., Berry, S., & Hays, R. D. (2001). Development of the 25-item national eye institute visual function questionnaire. Archives of Ophthalmology, 119(7), 1050–1058.PubMed Mangione, C. M., Lee, P. P., Gutierrez, P. R., Spritzer, K., Berry, S., & Hays, R. D. (2001). Development of the 25-item national eye institute visual function questionnaire. Archives of Ophthalmology, 119(7), 1050–1058.PubMed
30.
Zurück zum Zitat Matchar, D. B., Suner, I. J., Samsa, G. P., McCrory, D. C., Cline, K., & Lee, P. P. (2005). Measuring quality of life for patients with age-related macular degeneration. Rockville, MD: Technology Assessment Program, US Agency for Healthcare Research and Quality. Matchar, D. B., Suner, I. J., Samsa, G. P., McCrory, D. C., Cline, K., & Lee, P. P. (2005). Measuring quality of life for patients with age-related macular degeneration. Rockville, MD: Technology Assessment Program, US Agency for Healthcare Research and Quality.
31.
Zurück zum Zitat Mavranezouli, I., Brazier, J. E., Young, T. A. & Barkham, M. (2009). Using Rasch analysis to form plausible health states amenable to valuation: the development of CORE-6D from CORE-OM in order to elicit preferences for common mental health problems. Health Economics and Decision Science Discussion Paper Series No. 09/09: University of Sheffield. Mavranezouli, I., Brazier, J. E., Young, T. A. & Barkham, M. (2009). Using Rasch analysis to form plausible health states amenable to valuation: the development of CORE-6D from CORE-OM in order to elicit preferences for common mental health problems. Health Economics and Decision Science Discussion Paper Series No. 09/09: University of Sheffield.
32.
Zurück zum Zitat Mangione, C. M. (2000). NEI VFQ-25 scoring algorithm. Rockville, MD: National Eye Institute. Mangione, C. M. (2000). NEI VFQ-25 scoring algorithm. Rockville, MD: National Eye Institute.
33.
Zurück zum Zitat Mangione, C. M., Lee, P. P., Pitts, J., Gutierrez, P., Berry, S., Hays, R. D., et al. (1998). Psychometric properties of the national eye institute visual function questionnaire (NEI-VFQ). Archives of Ophthalmology, 116(11), 1496–1504.PubMed Mangione, C. M., Lee, P. P., Pitts, J., Gutierrez, P., Berry, S., Hays, R. D., et al. (1998). Psychometric properties of the national eye institute visual function questionnaire (NEI-VFQ). Archives of Ophthalmology, 116(11), 1496–1504.PubMed
34.
Zurück zum Zitat Revicki, D., Rentz, A., Harnam, N., Thomas, V. & Lanzetta, P. (2010). Reliability and validity of the national eye institute visual function questionnaire-25 in patients with age-related macular degeneration. Investigative Ophthalmology and Visual Science, 51(2), 712–717. Revicki, D., Rentz, A., Harnam, N., Thomas, V. & Lanzetta, P. (2010). Reliability and validity of the national eye institute visual function questionnaire-25 in patients with age-related macular degeneration. Investigative Ophthalmology and Visual Science, 51(2), 712–717.
35.
Zurück zum Zitat Submacular Surgery Trials Research Group. (2005). Health-related quality of life among patients with ocular histoplasmosis or idiopathic choroidal neovascularization at enrollment in a randomized trial of submacular surgery. SST report no. 5. Archives of Ophthalmology 123, 78–88. Submacular Surgery Trials Research Group. (2005). Health-related quality of life among patients with ocular histoplasmosis or idiopathic choroidal neovascularization at enrollment in a randomized trial of submacular surgery. SST report no. 5. Archives of Ophthalmology 123, 78–88.
36.
Zurück zum Zitat Clemons, T. E., Chew, E. Y., Bressler, S. B., & McBee, W. (2003). National eye institute visual function questionnaire in the age-related eye disease study (AREDS): AREDS report no. 10. Archives of Ophthalmology, 121(2), 211–217.PubMed Clemons, T. E., Chew, E. Y., Bressler, S. B., & McBee, W. (2003). National eye institute visual function questionnaire in the age-related eye disease study (AREDS): AREDS report no. 10. Archives of Ophthalmology, 121(2), 211–217.PubMed
37.
Zurück zum Zitat Lindblad, A. S., & Clemons, T. E. (2005). Responsiveness of the national eye institute visual function questionnaire to progression to advanced age-related macular degeneration, vision loss, and lens opacity: AREDS report no. 14. Archives of Ophthalmology, 123(9), 1207–1214.PubMedCrossRef Lindblad, A. S., & Clemons, T. E. (2005). Responsiveness of the national eye institute visual function questionnaire to progression to advanced age-related macular degeneration, vision loss, and lens opacity: AREDS report no. 14. Archives of Ophthalmology, 123(9), 1207–1214.PubMedCrossRef
38.
Zurück zum Zitat Suner, I. J., Kokame, G. T., Yu, E., Ward, J., Dolan, C., & Bressler, N. M. (2009). Responsiveness of NEI VFQ-25 to changes in visual acuity in neovascular AMD: Validation studies from two phase 3 clinical trials. Investigative Ophthalmology and Visual Science, 50(8), 3629–3635.PubMedCrossRef Suner, I. J., Kokame, G. T., Yu, E., Ward, J., Dolan, C., & Bressler, N. M. (2009). Responsiveness of NEI VFQ-25 to changes in visual acuity in neovascular AMD: Validation studies from two phase 3 clinical trials. Investigative Ophthalmology and Visual Science, 50(8), 3629–3635.PubMedCrossRef
39.
Zurück zum Zitat Bond, T. G., & Fox, C. M. (2007). Applying the Rasch model: Fundamental measurement in the human sciences. London: Psychology Press. Bond, T. G., & Fox, C. M. (2007). Applying the Rasch model: Fundamental measurement in the human sciences. London: Psychology Press.
40.
Zurück zum Zitat Wright, B. D., & Masters, G. N. (1982). Rating scale analysis: Rasch measurement. Chicago: MESA Press. Wright, B. D., & Masters, G. N. (1982). Rating scale analysis: Rasch measurement. Chicago: MESA Press.
41.
Zurück zum Zitat Rasch, G. (1980). Probabilistic models for some intelligence and attainment tests. Chicago: University of Chicago Press. Rasch, G. (1980). Probabilistic models for some intelligence and attainment tests. Chicago: University of Chicago Press.
42.
Zurück zum Zitat Linacre, J. M. (1999). Investigating rating scale category utility. Journal of Outcome Measurement, 3(2), 103–122.PubMed Linacre, J. M. (1999). Investigating rating scale category utility. Journal of Outcome Measurement, 3(2), 103–122.PubMed
43.
Zurück zum Zitat Kubinger, K. D. (2005). Psychological test calibration using the Rasch model-some critical suggestions on traditional approaches. International Journal of Testing, 5(4), 377–394.CrossRef Kubinger, K. D. (2005). Psychological test calibration using the Rasch model-some critical suggestions on traditional approaches. International Journal of Testing, 5(4), 377–394.CrossRef
44.
Zurück zum Zitat RUMM 2020. (2004). Rasch unidimensional measurement models. Australia: RUMM Laboratory Pty Ltd. RUMM 2020. (2004). Rasch unidimensional measurement models. Australia: RUMM Laboratory Pty Ltd.
45.
Zurück zum Zitat Kind, P., & Macran, S. (2005). Eliciting social preference weights for functional assessment of cancer therapy-lung health states. Pharmacoeconomics, 23(11), 1143–1153.PubMedCrossRef Kind, P., & Macran, S. (2005). Eliciting social preference weights for functional assessment of cancer therapy-lung health states. Pharmacoeconomics, 23(11), 1143–1153.PubMedCrossRef
46.
Zurück zum Zitat Allergan Inc. A study of the safety and efficacy of a new treatment for macular edema resulting from retinal vein occlusion. Baseline data on file at Allergan Inc. Allergan Inc. A study of the safety and efficacy of a new treatment for macular edema resulting from retinal vein occlusion. Baseline data on file at Allergan Inc.
47.
Zurück zum Zitat Allergan Inc. A study of safety and efficacy of a new treatment for diabetic Macular Edema. Baseline data on file at Allergan Inc. Allergan Inc. A study of safety and efficacy of a new treatment for diabetic Macular Edema. Baseline data on file at Allergan Inc.
48.
Zurück zum Zitat Schiffman, R. M., Walt, J. G., Jacobsen, G., Doyle, J. J., Lebovics, G., & Sumner, W. (2003). Utility assessment among patients with dry eye disease. Ophthalmology, 110(7), 1412–1419.PubMedCrossRef Schiffman, R. M., Walt, J. G., Jacobsen, G., Doyle, J. J., Lebovics, G., & Sumner, W. (2003). Utility assessment among patients with dry eye disease. Ophthalmology, 110(7), 1412–1419.PubMedCrossRef
49.
Zurück zum Zitat Globe, D. R., Wu, J., Azen, S. P., & Varma, R. (2004). The impact of visual impairment on self-reported visual functioning in Latinos: The Los Angeles Latino eye study. Ophthalmology, 111(6), 1141–1149.PubMedCrossRef Globe, D. R., Wu, J., Azen, S. P., & Varma, R. (2004). The impact of visual impairment on self-reported visual functioning in Latinos: The Los Angeles Latino eye study. Ophthalmology, 111(6), 1141–1149.PubMedCrossRef
50.
Zurück zum Zitat Allergan Inc. Memantine in patients with chronic Glaucoma. Baseline data on file at Allergan Inc. Allergan Inc. Memantine in patients with chronic Glaucoma. Baseline data on file at Allergan Inc.
51.
Zurück zum Zitat Muir, K. W., Santiago-Turla, C., Stinnett, S. S., Herndon, L. W., Allingham, R. R., Challa, P., et al. (2006). Health literacy and adherence to glaucoma therapy. American Journal of Ophthalmology, 142(2), 223–226.PubMedCrossRef Muir, K. W., Santiago-Turla, C., Stinnett, S. S., Herndon, L. W., Allingham, R. R., Challa, P., et al. (2006). Health literacy and adherence to glaucoma therapy. American Journal of Ophthalmology, 142(2), 223–226.PubMedCrossRef
Metadaten
Titel
Rasch analysis in the development of a simplified version of the national eye institute visual-function questionnaire-25 for utility estimation
verfasst von
Jonathan W. Kowalski
Anne M. Rentz
John G. Walt
Andrew Lloyd
Jeff Lee
Tracey A. Young
Wen-Hung Chen
Neil M. Bressler
Paul Lee
John E. Brazier
Ron D. Hays
Dennis A. Revicki
Publikationsdatum
01.03.2012
Verlag
Springer Netherlands
Erschienen in
Quality of Life Research / Ausgabe 2/2012
Print ISSN: 0962-9343
Elektronische ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-011-9938-z

Weitere Artikel der Ausgabe 2/2012

Quality of Life Research 2/2012 Zur Ausgabe